Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will be a prominent presence as a scientific contributor to the upcoming World Biopharm Forum in Oxford, England.
The enGenes presentation to the conference will detail the recent progress it has made as part of the ECOnti consortium towards continuous biomolecule production in E. coli for reduced footprint microbial manufacturing.
Biopharma manufacturing innovation
The Austrian Government-funded ECOnti project is seeking to develop an accelerated, low ecological footprint, manufacturing platform for continuous production of biotechnological products that features a fully integrated and automated continuous upstream and downstream process at up to 10 L batch size.
This project goals closely align with the 2023 World Biopharm Forum theme of ‘Democratization of Biotherapies: New Manufacturing Modalities & Intensifications’.